Anita Mahajan
Overview
Explore the profile of Anita Mahajan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
249
Citations
5209
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gajjar A, Mahajan A, Bale T, Bowers D, Canan L, Chi S, et al.
J Natl Compr Canc Netw
. 2025 Mar;
23(3):113-130.
PMID: 40073837
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pediatric Central Nervous System Cancers provide multidisciplinary diagnostic workup, staging, and treatment recommendations for diffuse high-grade gliomas and medulloblastomas in...
2.
Vora S, Pafundi D, Voss M, Buras M, Ashman J, Bendok B, et al.
Lancet Oncol
. 2024 Nov;
25(12):1625-1634.
PMID: 39571596
Background: Older patients (aged ≥65 years) with glioblastoma have a worse prognosis than younger patients and a median overall survival of 6-9 months. 3,4-Dihydroxy-6-[F]fluoro-L-phenylalanine (F-DOPA) PET sensitively and specifically identifies...
3.
Gunn H, Zaniletti I, Breen W, Leavitt T, Bogan A, Mahajan A, et al.
Neurooncol Pract
. 2024 Sep;
11(5):633-639.
PMID: 39279768
Background: Minimal clinically important differences (MCIDs) quantify the clinical relevance of quality of life results at the individual patient and group level. The aim of this study was to estimate...
4.
Frechette K, Breen W, Brown P, Sener U, Webb L, Routman D, et al.
Biomedicines
. 2024 Aug;
12(8).
PMID: 39200256
Leptomeningeal disease (LMD) is a devastating sequelae of metastatic spread that affects approximately 5% of cancer patients. The incidence of LMD is increasing due to advancements in systemic therapy and...
5.
Paganetti H, Simone 2nd C, Bosch W, Haas-Kogan D, Kirsch D, Li H, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jul;
121(1):202-217.
PMID: 39059509
This position paper, led by the NRG Oncology Particle Therapy Work Group, focuses on the concept of relative biologic effect (RBE) in clinical proton therapy (PT), with the goal of...
6.
McKone E, Breen W, Foster N, Bogan A, Connors M, Alstat R, et al.
Int J Radiat Oncol Biol Phys
. 2024 Jul;
120(4):1032-1038.
PMID: 39001719
Purpose: Memantine is standard in certain adults receiving brain radiation therapy (RT) to decrease cognitive impacts, but it is unknown whether pediatric patients can take, tolerate, and/or benefit from memantine....
7.
Tang X, Deisher A, Mundy D, Kruse J, Mahajan A, Qian J, et al.
Int J Part Ther
. 2024 May;
11:100007.
PMID: 38757073
Purpose: The breakpoint for a 360° radiotherapy gantry is typically positioned at 180°. This arbitrary setting has not been systematically evaluated for efficiency and may cause redundant gantry rotation and...
8.
Hong S, Shinya Y, Mahajan A, Laack N, OBrien E, Stokken J, et al.
Neurosurg Focus
. 2024 May;
56(5):E4.
PMID: 38691852
Objective: This study aimed to provide data on extended outcomes in primary clival chordomas, focusing on progression-free survival (PFS) and overall survival (OS). Methods: A retrospective single-center analysis was conducted...
9.
Hong S, Shinya Y, Lakomkin N, Mahajan A, Laack N, OBrien E, et al.
World Neurosurg
. 2024 Apr;
187:e321-e330.
PMID: 38649026
Objective: To assess the impact of tumor extension into the occipital condyle (OC) in lower clival chordoma management and the need for occipito-cervical fusion (OCF). Methods: A retrospective analysis was...
10.
Dupere J, Lucido J, Breen W, Mahajan A, Remmes N
Int J Radiat Oncol Biol Phys
. 2024 Apr;
119(1):307-308.
PMID: 38631744
No abstract available.